CIBC Bank USA’s DexCom DXCM Stock Holding History

CIBC Bank USA’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$224K	Buy	+4,100	New	+$194K	0.03%	257
2019 Q3	–	Sell	-6,300	Closed	-$236K	–	273
2019 Q2	$236K	Buy	+6,300	New	+$198K	0.03%	237
2018 Q4	–	Sell	-7,480	Closed	-$268K	–	250
2018 Q3	$268K	Buy	+7,480	New	+$232K	0.04%	215
2017 Q2	–	Sell	-9,860	Closed	-$209K	–	275
2017 Q1	$209K	Buy	+9,860	New	+$192K	0.03%	242
2016 Q4	–	Sell	-10,060	Closed	-$220K	–	262
2016 Q3	$220K	Buy	+10,060	New	+$224K	0.03%	230
2016 Q1	–	Sell	-10,400	Closed	-$213K	–	240
2015 Q4	$213K	Hold	10,400	–	–	0.04%	218
2015 Q3	$223K	Hold	10,400	–	–	0.04%	217
2015 Q2	$208K	Buy	+10,400	New	+$183K	0.03%	249

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

CIBC Bank USA's DXCM Position: Q4 2019 in Review

CIBC Bank USA opened a new position in DexCom (DXCM) in Q4 2019: 4,100 shares worth $224K. The stake represents 0.03% of the portfolio and ranks #257 among its holdings. This is a return to the name: CIBC Bank USA previously reported a position in DXCM as recently as Q2 2019.

CIBC Bank USA first reported a position in DXCM in Q2 2015 and has held it in 8 quarters since. The position peaked at $268K in Q3 2018. 509 funds tracked by Wall St. Rank hold DXCM as of Q4 2019.

CIBC Bank USA held 4,100 shares of DexCom worth $224K as of Q4 2019.
DexCom was a new CIBC Bank USA position in Q4 2019.
DexCom made up 0.03% of CIBC Bank USA's portfolio in Q4 2019, its #257 holding.
CIBC Bank USA first reported a position in DexCom in Q2 2015 and has held it in 8 quarters since.
CIBC Bank USA's DexCom position peaked at $268K in Q3 2018.
509 funds tracked by Wall St. Rank held DexCom as of Q4 2019.

Based on CIBC Bank USA's 13F filing for Q4 2019, filed 29 Jan 2020.